Note: UC CAI is administered in part by UC BRAID - the UC Biomedical Research Acceleration, Integration, and Development consortium.
The second round of funding opportunities for the Technology Development Award from the University of California Center for Accelerated Innovation (UC CAI) has begun. All faculty at UC campuses in Davis, Irvine, Los Angeles, San Diego and San Francisco are eligible.
The program offers four $200,000 awards to projects that help accelerate cutting-edge science to directly benefit patients with heart, lung and blood diseases. The program is unique to the UC system; it’s a collaborative effort among the five UC medical campuses and the National Institutes of Health Heart, Lung and Blood Institute.
To be considered for funding, projects must have existing or imminent data showing the effectiveness of their technology and a clear clinical use. Therapeutic areas can cover any health condition within NIH NHLBI disease domains (heart, lung, sleep, blood) where there is an unmet medical need or the potential for significant improvement.
The first four $200,000 grants were awarded in June.
Two UCSF recipients received funding for their clinical projects:
- Charles Chiu, MD, Phd
- Stephen Nishimura, MD